ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

86
Analysis
Health Care • India
Laurus Labs is a research-driven, integrated pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients (APIs), generic formulations, and Contract Development and Manufacturing Organization (CDMO) services. The company is a global leader in antiretroviral (ARV) APIs and has diversified into oncology, cardiovascular, and biotechnology segments. Laurus Labs is headquartered in Hyderabad, India, and was founded in 2005.
more
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
5.1k Views
Share
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
•02 Feb 2026 07:49

NIFTY MIDCAP150 Index Rebalance Preview: 15 Potential Changes in March

There could be 15 changes in March. Estimated one-way turnover is 9.8% and round-trip trade is INR 26.5bn. With over US$43bn tracking the index...

Logo
361 Views
Share
bullish•Laurus Labs
•24 Sep 2025 10:30

Business Breakdown: Laurus Labs- Breaking ARV Dependence with High-Margin Businesses?

​Laurus Labs shifts focus from ARV APIs to high-growth CDMO and biotech sectors for long-term stability and profitability in the pharma industry.

Logo
415 Views
Share
•01 Jul 2025 07:30

AMFI Stock Reclassification Preview (Jun 2025): Active Flows Lead to Passive Flows

We currently forecast 44 migrations for the AMFI July reclassification. Some IPOs could be added to Large/Mid cap. The forecast upward migrations...

Logo
884 Views
Share
x